Comparison between Single-Dose Esomeprazole- and Pantoprazole-Based Triple Therapy on the Effectiveness for <i>Helicobacter pylori</i> Eradication in Taiwanese Population

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td align="left"></td><td align="left">EAC group <br/>(<i>n</i> = 208)</td><td align="center">PAC group <br/> (<i>n</i> = 245)</td><td align="center"><i>P</i> value</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td align="left">Eradication rate</td><td align="left"></td><td align="left"></td><td align="left"></td></tr><tr><td align="left"> Intention-to-treat</td><td align="center">72% (150/208)</td><td align="center">55% (135/245)</td><td align="center">&lt;.05</td></tr><tr><td align="left"> Per-protocol</td><td align="center">91% (150/165)</td><td align="center">72% (135/187)</td><td align="center">&lt;.05</td></tr><tr><td align="left">Adverse events</td><td align="center">19% (39/208)</td><td align="center">17% (42/245)</td><td align="center">.712</td></tr><tr><td align="left">Compliance</td><td align="center">87% (181/208)</td><td align="center">91% (223/245)</td><td align="center">.083</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Outcomes of esomeprazole- and pantoprazole-based triple therapy.

Gastroenterology Research and Practice

tab2

Table 2

Table 2: Comparison between Single-Dose Esomeprazole- and Pantoprazole-Based Triple Therapy on the Effectiveness for <i>Helicobacter pylori</i> Eradication in Taiwanese Population 

Table 2 | Comparison between Single-Dose Esomeprazole- and Pantoprazole-Based Triple Therapy on the Effectiveness for Helicobacter pylori Eradication in Taiwanese Population 